The Application segment of the Animal Ultrasonic Cutting Hemostat Knife market is divided into three sub‑categories: small‑animal surgery, large‑animal surgery, and research & development. Small‑animal surgery, which includes procedures on companion species such as dogs and cats, accounts for the largest share because of higher procedure frequency and greater adoption of minimally invasive techniques. Large‑animal surgery, covering livestock and equine procedures, contributes a substantial portion driven by the need for rapid hemostasis in field conditions. The research & development sub‑category, encompassing pre‑clinical studies and device validation, adds a niche but growing share as academic and biotech institutions expand ultrasonic cutting applications. Collectively, these application sub‑segments define the overall market size, with the relative weight of each reflecting procedural volume, regulatory acceptance, and investment in innovation. This breakdown illustrates the core of the Animal Ultrasonic Cutting Hemostat Knife segmentation and supports forecasting by linking usage patterns to revenue streams.